Chronic tendinopathy is characterized by failed healing response, disorganized collagen matrix (tendinosis), reduced tenocyte activity, and inadequate vascularization, all of which align directly with BPC-157's documented mechanisms of fibroblast stimulation, collagen remodeling, and angiogenesis
99 % purity without an attached chromatogram is a claim, not proof
Unlike narrow-spectrum peptides, BPC-157 simultaneously modulates angiogenic, cytoprotective, and anti-inflammatory pathwayswithout systemic hormone effects
Published trials used oral doses of 0.25 mg to 30 mg per day and intravenous single doses of 25 to 400 mcg/kg
Weight loss for both the pill and injection may increase when you get closer to your full maintenance dose, usually after a few months